89 results
8-K
EX-1.1
AQST
Aquestive Therapeutics Inc
21 Mar 24
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
assessment, fine or penalty levied against them (except for any such taxes, assessments fines or penalties currently being contested in good faith
8-K
EX-10.2
ag27vene3
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.1
7kxsymrdzzqf4ur3g
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.3
sx8b9dcpsi1cf2sv1 6s
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-99.1
hllgvdvk90z0a1
11 Aug 23
Advancing medicines. Solving problems. Improving lives. Advancing medicines. Solving problems. Improving lives. Corporate Presentation August 2023 1
1:14pm
S-8
EX-4.1
nggo6cc2qeywpx t9jqo
9 Aug 23
Registration of securities for employees
5:22pm
8-K
EX-99.1
q8q8sk
27 Jul 23
Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm™ (epinephrine) Sublingual Film
9:23am
8-K
EX-99.1
aajrfwb9k82
29 Jun 23
Advancing medicines. Solving problems. Improving lives. Corporate Presentation June 2023 1
9:05am
PRE 14A
uqtucj004lh1e7v
18 Apr 23
Preliminary proxy
8:50am